News on HPV continually updated from thousands of sources around the net.
Cervical Screening Awareness Month is coming up in September and MidCentral DHB is encouraging women who are due, or overdue, to book a smear test now.
Corresponding preparer: Lauri E. Markowitz, MD, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC.
A new report from a working group convened by the International Agency for Research on Cancer , the specialized cancer agency of the World Health Organization, and the United States National Cancer Institute shows how the evaluation and licensing of prophylactic human papillomavirus vaccines could be significantly accelerated.
The Center for Disease Control released late July their National Immunization Survey for Teens data showing that Human Papillomavirus coverage increased "significantly" from 2012 to 2013 in only five states, with South Carolina among those states and heralded as an example of positive response to advocacy.
Many young adults are back on college campuses and living in dorms, so the Arizona Department of Health is recommending they take an extra step to protect themselves.
Trovagene, Inc. , a developer of cell-free molecular diagnostics, announced today that results from two independent clinical studies were presented at the 29th International Papillomavirus Conference.
The vaccine against the sexually transmitted infection known as HPV has proved to be a tough sell, but a group of local grandmothers has taken on the challenge.
Sherri Tyrrell, of Bend, holds up 28 samples of high risk HPV test samples inside Central Oregon Pathology in Bend, Oregon on Friday, August 22, 2014.
Immunizations prevent disease, save lives, and give people a better and longer quality of life, which is why the Onslow County Health Department is inviting area residents to celebrate August as National Immunization Awareness Month.
A new long-term study shows that the human papillomavirus vaccine appears to protect against the sexually transmitted virus for at least eight years.
While prophylactic human papilloma virus vaccination is considered effective in young girls, it is unclear whether a catch-up vaccination of older girls would be beneficial.
Research presented at the 29 Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent of all cervical cancer.
A small San Diego biotech has identified a drug that appears to prevent several subtypes of the human papillomavirus from replicating-including the two HPV subtypes that cause 70 percent of all cases of cervical cancer.
If you have an adolescent son or daughter, you might be wrestling with a big question: Whether to get your child the HPV vaccine.
Updated: Fri Aug 29, 2014 07:36 am
Copyright © 2014 Topix LLC